SURZETOCLAX
UNII C3TU3CHH6L

Substance Identification & Data

This profile provides standardized clinical and technical data for Surzetoclax, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C3TU3CHH6L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2858632-01-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C3TU3CHH6L

CAS Registry Number

2858632-01-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SURZETOCLAX

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C53H63ClN8O10S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AWGQQZVAXXLVMT-ORYVFAGJSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C206995

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

169450714

Unique identification number in the NCBI database of chemical substances.

INN ID

12915

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-36

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(cc3N(CCCOc3n1)c4c(C(=O)NS(=O)(=O)c5cc(c(cc5)NC[C@@H]6CC[C@H](CO6)OC)[N+](=O)[O-])ccc(c4)N7C[C@@H]8N(CC7)CC9=C(CC(C)(C)C[C@H]9OCCCOC8)c%10ccc(Cl)cc%10)cc[nH]2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Surzetoclax. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SURZETOCLAX

Common Names & Synonyms

ABBV 453 [WHO-DD]

D-ERYTHRO-HEXITOL, 1,5-ANHYDRO-6-((4-(((4-((4AS,10AR)-14-(4-CHLOROPHENYL)-1,2,4A,5,8,9,10A,11,13,15-DECAHYDRO-12,12-DIMETHYL-7H,12H-PYRAZINO(2,1-G)(1,5,8)BENZODIOXAAZACYCLOUNDECIN-3(4H)-YL)-2-(3,4-DIHYDRO-2H-PYRROLO(3',2':5,6)PYRIDO(2,3-B)(1,4)OXAZEPIN-1(7H)-YL)BENZOYL)AMINO)SULFONYL)-2-NITROPHENYL)AMINO)-3,4,6-TRIDEOXY-2-O-METHYL-

SURZETOCLAX [INN]

SURZETOCLAX [USAN]

Systematic Nomenclature

1,5-ANHYDRO-6-((4-(((4-((4AS,10AR)-14-(4-CHLOROPHENYL)-1,2,4A,5,8,9,10A,11,13,15-DECAHYDRO-12,12-DIMETHYL-7H,12H-PYRAZINO(2,1-G)(1,5,8)BENZODIOXAAZACYCLOUNDECIN-3(4H)-YL)-2-(3,4-DIHYDRO-2H-PYRROLO(3',2':5,6)PYRIDO(2,3-B)(1,4)OXAZEPIN-1(7H)-YL)BENZOYL)AMINO)SULFONYL)-2-NITROPHENYL)AMINO)-3,4,6-TRIDEOXY-2-O-METHYL-D-ERYTHRO-HEXITOL

SYS

4-((4AS,10AR)-14-(4-CHLOROPHENYL)-12,12-DIMETHYL-1,2,4A,5,8,9,10A,11,13,15-DECAHYDRO-7H,12HPYRAZINO( 2,1-G)(1,5,8)BENZODIOXAAZACYCLOUNDECIN-3(4H)-YL)-2-(3,4-DIHYDRO-2HPYRROLO( 3',2':5,6)PYRIDO(2,3-B)(1,4)OXAZEPIN-1(7H)-YL)-N-(4-((((2S,5R)-5-METHOXYOXAN-2-YL)METHYL)AMINO)-3-NITROBENZENE-1-SULFONYL)BENZAMIDE

SYS